Navigation Links
Somanetics Corporation to Present at Rodman & Renshaw Annual Global Investment Conference
Date:11/3/2008

- Somanetics to Webcast Presentation on November 10, 2008 at 4:30 P.M. ET -

TROY, Mich., Nov. 3 /PRNewswire-FirstCall/ -- Somanetics Corporation (Nasdaq: SMTS) today announced it will present at the Rodman & Renshaw Annual Global Investment Conference at the New York Palace Hotel in New York. William Iacona, Somanetics' chief financial officer, will make a 25-minute presentation on Monday, November 10, 2008 at 4:30 p.m. ET. The presentation will be webcast live. The webcast may be accessed by visiting the Investor Center section of Somanetics' website at http://www.somanetics.com . The presentation also will be archived on Somanetics' website for 30 days following the conference.

About Somanetics

Somanetics Corporation (Nasdaq: SMTS) develops, manufactures and markets the INVOS(R) Cerebral/Somatic Oximeter, a non-invasive patient monitoring system that continuously measures changes in the blood oxygen levels in the brain and elsewhere in the body in patients with or at risk for restricted blood flow. Surgeons, anesthesiologists and other medical professionals can use the information provided by the INVOS System, in conjunction with other available information, to identify oxygen imbalances in tissues beneath the sensor and take necessary corrective action, potentially improving patient outcomes and reducing the costs of care. The INVOS System has a nearly 11-year market track record supported by more than 600 clinical references, and is used at nearly 700 U.S. hospitals. Somanetics supports its customers through a direct U.S. sales force and clinical education team. Covidien markets INVOS System products in Europe, Canada, the Middle East and South Africa and Edwards Lifesciences represents INVOS System products in Japan. For more information visit http://www.somanetics.com .


'/>"/>
SOURCE Somanetics Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Somanetics Announces Share Repurchase Program Increased By $15 Million
2. Somanetics Receives 510(k) Clearance From the FDA to Expand INVOS System Labeling
3. Somanetics Corporation to Present at Citigroup 2008 Healthcare Conference
4. Somanetics Announces Share Repurchase Program Increased by $15 Million
5. Somanetics Announces Share Repurchase Program
6. Somanetics Reports Financial Results for the First Quarter of Fiscal 2008
7. Somanetics Corporation to Release First Quarter 2008 Financial Results and Host Conference Call March 18, 2008
8. Somanetics Corporation to Release Fourth Quarter and Fiscal 2007 Financial Results and Host Conference Call January 23, 2008
9. Somanetics Corporation to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
10. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
11. STERIS Corporation Announces Webcast of Analyst Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... 08, 2016 , ... California Senate Bill (SB) 863, signed into law in ... 2013 and 2014, according to CompScope™ Medical Benchmarks for California, 17th Edition , ... the study, medical payments per claim in California decreased 4 percent in 2013 and ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... and financial planning services from offices headquartered in Hamilton County, is embarking on ... LuvFurMutts. , LuvFurMutts specializes in finding new homes for orphaned or neglected senior ...
(Date:12/8/2016)... ... December 08, 2016 , ... Coffey Agencies, a ... and commercial clients in the northern Alabama and Georgia regions, is embarking on ... 1977, Nobis Works has built a network of support and education facilities to ...
(Date:12/7/2016)... ... 2016 , ... Kenall Manufacturing, a leader in sealed healthcare lighting for more ... a multi-function, sealed, LED luminaire that meets the needs of everyone in the patient ... , A 2’ x 4’ model features four modes: reading, ambient, standard ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... S.L. (“Presence”) for a purchase price of approximately $17.4 million (net of ... annual revenue is approximately $13.2 million. Headquartered in Barcelona, Spain, Presence is ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016  Valeant Pharmaceuticals ... TSX: VRX) ("Valeant") today announced positive results from ... study to assess the safety and efficacy of ... treatment of plaque psoriasis. Within ... with moderate to severe psoriasis, IDP-118 showed statistical ...
(Date:12/8/2016)... Mederi Therapeutics Inc . hat die behördliche Zulassung durch ... gastroösophageale Refluxerkrankung (GERD) – in China angekündigt. ... ... Live Stretta procedure performed and broadcast during ... Endoscopy at Wuhan Union Hospital ...
(Date:12/8/2016)...  Boehringer Ingelheim announced today that it has been ... is the ninth time that the company received a ... Place to Work for LGBT Equality. Administered by the ... benchmarking report on corporate policies and practices related to ... employees. "We are committed to creating ...
Breaking Medicine Technology: